Inhibrx Biosciences (INBX) Assets Average: 2024-2025
Historic Assets Average for Inhibrx Biosciences (INBX) over the last 1 years, with Sep 2025 value amounting to $194.8 million.
- Inhibrx Biosciences' Assets Average fell 19.00% to $194.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.8 million, marking a year-over-year decrease of 19.00%. This contributed to the annual value of $244.3 million for FY2024, which is N/A change from last year.
- Inhibrx Biosciences' Assets Average amounted to $194.8 million in Q3 2025, which was down 14.33% from $227.4 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Assets Average registered a high of $240.5 million during Q3 2024, and its lowest value of $194.8 million during Q3 2025.
- For the 2-year period, Inhibrx Biosciences' Assets Average averaged around $215.2 million, with its median value being $211.7 million (2025).
- Data for Inhibrx Biosciences' Assets Average shows a maximum YoY dropped of 19.00% (in 2025) over the last 5 years.
- Quarterly analysis of 2 years shows Inhibrx Biosciences' Assets Average stood at $201.7 million in 2024, then declined by 19.00% to $194.8 million in 2025.
- Its Assets Average stands at $194.8 million for Q3 2025, versus $227.4 million for Q2 2025 and $211.7 million for Q1 2025.